Genetix aims for digital pathology success to aid growth
This article was originally published in Clinica
Executive Summary
Since its inception in 1991, cellular imaging and analysis specialist Genetix has developed technology designed to aid drug discovery, genetic testing such as prenatal and postnatal screening, and cancer diagnostics including solid tumour testing and leukaemia diagnosis.